Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros




Intervalo de año de publicación
1.
An. bras. dermatol ; An. bras. dermatol;93(5): 680-685, Sept.-Oct. 2018. tab
Artículo en Inglés | LILACS | ID: biblio-949949

RESUMEN

Abstract: Background: Mycosis fungoides (MF) is the most common subtype of cutaneous T-cell lymphoma. TNMB system is the staging method used in MF, and it not only guides therapeutic management, but represents the main prognostic factor. In order to improve the prognostic evaluation, the Cutaneous Lymphoma International Prognostic Index (CLIPi) was proposed. Objective: To evaluate the performance of CLIPi score for prognostic analysis in patients with early stage MF. Methods: This is a retrospective cross-sectional observational study, with exploratory analysis. The outcome variables were disease progression and related death. Results: One hundred and two patients were stratified according to CLIPi score, being the majority classified as low risk. Patients with intermediate or high risk presented disease progression more frequently than those with low risk (PR: 1.2 / p = 0.004 / 95%CI: 1.0 - 1.6). The same did not occur with the variable related death. In addition, survival rates were not consistent with risk stratification. Study Limitations: Small sample and its retrospective analysis. Conclusions: Since CLIPi score was proposed, four other studies that we could consult showed conflicting results, similar to the present study. Further studies are necessary for a recommendation of its use.


Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Neoplasias Cutáneas/patología , Micosis Fungoide/patología , Pronóstico , Neoplasias Cutáneas/mortalidad , Brasil/epidemiología , Estudios Transversales , Tasa de Supervivencia , Estudios Retrospectivos , Estudios de Seguimiento , Linfoma Cutáneo de Células T/mortalidad , Linfoma Cutáneo de Células T/patología , Micosis Fungoide/mortalidad , Síndrome de Sézary/patología , Progresión de la Enfermedad , Estadificación de Neoplasias
2.
An Bras Dermatol ; 93(5): 680-685, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30156617

RESUMEN

BACKGROUND: Mycosis fungoides (MF) is the most common subtype of cutaneous T-cell lymphoma. TNMB system is the staging method used in MF, and it not only guides therapeutic management, but represents the main prognostic factor. In order to improve the prognostic evaluation, the Cutaneous Lymphoma International Prognostic Index (CLIPi) was proposed. OBJECTIVE: To evaluate the performance of CLIPi score for prognostic analysis in patients with early stage MF. METHODS: This is a retrospective cross-sectional observational study, with exploratory analysis. The outcome variables were disease progression and related death. RESULTS: One hundred and two patients were stratified according to CLIPi score, being the majority classified as low risk. Patients with intermediate or high risk presented disease progression more frequently than those with low risk (PR: 1.2 / p = 0.004 / 95%CI: 1.0 - 1.6). The same did not occur with the variable related death. In addition, survival rates were not consistent with risk stratification. STUDY LIMITATIONS: Small sample and its retrospective analysis. CONCLUSIONS: Since CLIPi score was proposed, four other studies that we could consult showed conflicting results, similar to the present study. Further studies are necessary for a recommendation of its use.


Asunto(s)
Micosis Fungoide/patología , Neoplasias Cutáneas/patología , Brasil/epidemiología , Estudios Transversales , Progresión de la Enfermedad , Estudios de Seguimiento , Humanos , Linfoma Cutáneo de Células T/mortalidad , Linfoma Cutáneo de Células T/patología , Masculino , Persona de Mediana Edad , Micosis Fungoide/mortalidad , Estadificación de Neoplasias , Pronóstico , Estudios Retrospectivos , Síndrome de Sézary/patología , Neoplasias Cutáneas/mortalidad , Tasa de Supervivencia
3.
J. bras. med ; 78(6): 44-50, jun. 2000. tab
Artículo en Portugués | LILACS | ID: lil-270131

RESUMEN

Neste artigo a abordagem terapêutica atual da sífilis é revisada, baseada em seus estágios clínicos e laboratoriais. Resumem-se suas opções terapêuticas e controle de cura, obtendo-se assim o conhecimento atual necessário para a melhor atuação no atendimento médico


Asunto(s)
Humanos , Penicilinas/uso terapéutico , Sífilis/diagnóstico , Sífilis/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA